Home›People›Sean O'Neill
Sean O'Neill

Sean O'Neill

Independent board member of Araceli Biosciences, a high-content imaging technology company.

Director
Updated Nov 6, 2026·Latest SEC filing Nov 3, 2026·Suggest an edit

About Sean O'Neill

Sean O'Neill is an independent board member of Araceli Biosciences, a company that builds scalable high-content imaging technology. He works as a private investor in technology-driven companies, including an investment in Phoseon Technology that Excelitas Technologies later acquired.

Earlier in his career, O'Neill led the Machine Vision Centre at Trinity College Dublin, and MV Technology Ltd. was later acquired by Agilent Technology Inc.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Sean O'Neill in the role, so the role may have started earlier or lasted longer.

Araceli Biosciences Inc. Current
Independent Board Member
2023 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.

Key Colleagues at Startups

The people Sean O'Neill works with at each company, as listed on that company's latest Form D.

Araceli Biosciences Inc. · Form D, Nov 3, 2026
Matt Beaudet
Matt Beaudet
President and CEO, director
WC
William Cortelyou
Chairman of the Board
Kirk Malloy
Kirk Malloy
Director
SR
Samraat Raha
Director
Bruce Rhine
Bruce Rhine
Director

Sources

  1. SECAraceli Biosciences Inc. Form D, filed Nov 3, 2026
  2. company_siteAraceli Biosciences home page